Ultrahypofractionation Should be a Standard of Care Option for Intermediate-Risk Prostate Cancer

被引：7
作者：
Loblaw, A. [1 ,2 ,3 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[3] Univ Toronto, Inst Hlth Care Policy Management & Evaluat, Toronto, ON, Canada
来源：
CLINICAL ONCOLOGY | 2020年 / 32卷 / 03期
关键词：
Prostate cancer; QOL; SABR; stereotactic body radiotherapy; DOSE-RATE BRACHYTHERAPY; EXTERNAL-BEAM RADIOTHERAPY; STEREOTACTIC ABLATIVE RADIOTHERAPY; QUALITY-OF-LIFE; RADIATION-THERAPY; RANDOMIZED-TRIAL; ONCOLOGIC OUTCOMES; NON-INFERIORITY; BOOST; SCHEDULES;
D O I：
10.1016/j.clon.2019.11.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：170 / 174
页数：5
相关论文
共 35 条
[1]   Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trials [J].
Alayed, Yasir ;
Quon, Harvey ;
Cheung, Patrick ;
Chu, William ;
Chung, Hans T. ;
Vesprini, Danny ;
Ong, Aldrich ;
Chowdhury, Amit ;
Panjwani, Dilip ;
Helou, Joelle ;
Pang, Geordi ;
Korol, Renee ;
Davidson, Melanie ;
Ravi, Ananth ;
McCurdy, Boyd ;
Zhang, Liying ;
Mamedov, Alexandre ;
Deabreu, Andrea ;
Commisso, Angela ;
Commisso, Kristina ;
Loblaw, Andrew .
RADIOTHERAPY AND ONCOLOGY, 2019, 140 :105-109
[2]   Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials [J].
Alayed, Yasir ;
Cheung, Patrick ;
Pang, Geordi ;
Mamedov, Alexandre ;
D'Alimonte, Laura ;
Deabreu, Andrea ;
Commisso, Kristina ;
Commisso, Angela ;
Zhang, Liang ;
Quon, Harvey C. ;
Musunuru, Hima Bindu ;
Helou, Joelle ;
Loblaw, D. Andrew .
RADIOTHERAPY AND ONCOLOGY, 2018, 127 (02) :213-218
[3]   Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial [J].
Aluwini, Shafak ;
Pos, Floris ;
Schimmel, Erik ;
van Lin, Emile ;
Krol, Stijn ;
van der Toorn, Peter Paul ;
de Jager, Hanja ;
Dirkx, Maarten ;
Alemayehu, Wendimagegn Ghidey ;
Heijmen, Ben ;
Incrocci, Luca .
LANCET ONCOLOGY, 2015, 16 (03) :274-283
[4]   Moderate Hypofractionation in High-Risk, Organ-Confined Prostate Cancer: Final Results of a Phase III Randomized Trial [J].
Arcangeli, Giorgio ;
Saracino, Biancamaria ;
Arcangeli, Stefano ;
Gomellini, Sara ;
Petrongari, Maria Grazia ;
Sanguineti, Giuseppe ;
Strigari, Lidia .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (17) :1891-+
[5]  
Brenner DJ, 2002, INT J RADIAT ONCOL, V52, P6
[6]   Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer [J].
Catton, Charles N. ;
Lukka, Himu ;
Gu, Chu-Shu ;
Martin, Jarad M. ;
Supiot, Stephane ;
Chung, Peter W. M. ;
Bauman, Glenn S. ;
Bahary, Jean-Paul ;
Ahmed, Shahida ;
Cheung, Patrick ;
Tai, Keen Hun ;
Wu, Jackson S. ;
Parliament, Matthew B. ;
Tsakiridis, Theodoros ;
Corbett, Tom B. ;
Tang, Colin ;
Dayes, Ian S. ;
Warde, Padraig ;
Craig, Tim K. ;
Julian, Jim A. ;
Levine, Mark N. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (17) :1884-+
[7]   Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement [J].
Chen, Ronald C. ;
Rumble, R. Bryan ;
Loblaw, D. Andrew ;
Finelli, Antonio ;
Ehdaie, Behfar ;
Cooperberg, Matthew R. ;
Morgan, Scott C. ;
Tyldesley, Scott ;
Haluschak, John J. ;
Tan, Winston ;
Justman, Stewart ;
Jain, Suneil .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (18) :2182-+
[8]   Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update [J].
Chin, Joseph ;
Rumble, R. Bryan ;
Kollmeier, Marisa ;
Heath, Elisabeth ;
Efstathiou, Jason ;
Dorff, Tanya ;
Berman, Barry ;
Feifer, Andrew ;
Jacques, Arthur ;
Loblaw, D. Andrew .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (15) :1737-+
[9]   Long-term oncologic outcomes of radical prostatectomy compared with brachytherapy-based approaches for intermediate- and high-risk prostate cancer [J].
Crook, Juanita .
BRACHYTHERAPY, 2015, 14 (02) :142-147
[10]   Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial [J].
Dearnaley, David ;
Syndikus, Isabel ;
Mossop, Helen ;
Khoo, Vincent ;
Birtle, Alison ;
Bloomfield, David ;
Graham, John ;
Kirkbride, Peter ;
Logue, John ;
Malik, Zafar ;
Money-Kyrle, Julian ;
O'Sullivan, Joe M. ;
Panades, Miguel ;
Parker, Chris ;
Patterson, Helen ;
Scrase, Christopher ;
Staffurth, John ;
Stockdale, Andrew ;
Tremlett, Jean ;
Bidmead, Margaret ;
Mayles, Helen ;
Naismith, Olivia ;
South, Chris ;
Gao, Annie ;
Cruickshank, Clare ;
Hassan, Shama ;
Pugh, Julia ;
Griffin, Clare ;
Hall, Emma .
LANCET ONCOLOGY, 2016, 17 (08) :1047-1060
1234